Literature DB >> 23569130

Enhancement of invasion of hepatocellular carcinoma cells through lysophosphatidic acid receptor.

Lianqing Lou1, Yong Xin Chen, Lingzhen Jin, Xiaofei Li, Xingfei Tao, Jinhong Zhu, Xiangyi Chen, Shuang Wu, Weiwei Ye, Jinke He, Guoqiang Ding.   

Abstract

OBJECTIVES: Lysophosphatidic acid (LPA) is a bioactive lipid mediator involved in tumour progression, cell invasion and metastasis. The mechanism of action of LPA in the invasive and metastatic capacity of human hepatocellular carcinoma (HCC) is not fully understood. This study investigated the effects of LPA on HCC cell invasion and induction of matrix metalloproteinase (MMP) -2 and -9.
METHODS: LPA receptor levels in HCC cell lines were detected by Western blot analysis; HCC cell invasion was analysed by the Transwell® system. The LPA receptor blocker Ki16425 was used to determine whether HCC cell invasion was LPA dependent. Expression of the MMP2 and MMP9 genes in HCC cells was determined by real-time quantitative reverse transcription-polymerase chain reaction (qPCR).
RESULTS: LPA increased HCC cell invasion, which was LPA-receptor dependent. Real-time RT-qPCR showed that LPA increased MMP9, but not MMP2, expression in HCC cells. Pharmacological inhibition of LPA receptors with Ki16452 significantly attenuated LPA-induced HCC cell invasion.
CONCLUSIONS: HCC invasiveness is facilitated by LPA and may be relevant to tumour progression. Thus, LPA receptors may be a potential therapeutic target for HCC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23569130     DOI: 10.1177/0300060512474124

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  8 in total

1.  Hepatoprotective and anti-tumor effects of targeting MMP-9 in hepatocellular carcinoma and its relation to vascular invasion markers.

Authors:  Mohammed A F Elewa; Mohammed M Al-Gayyar; Mona F Schaalan; Khaled H Abd El Galil; Mohamed A Ebrahim; Mamdouh M El-Shishtawy
Journal:  Clin Exp Metastasis       Date:  2015-05-22       Impact factor: 5.150

Review 2.  Role of autotaxin in cancer stem cells.

Authors:  Dongjun Lee; Dong-Soo Suh; Sue Chin Lee; Gabor J Tigyi; Jae Ho Kim
Journal:  Cancer Metastasis Rev       Date:  2018-09       Impact factor: 9.264

3.  Alternol inhibits migration and invasion of human hepatocellular carcinoma cells by targeting epithelial-to-mesenchymal transition.

Authors:  Xiao-lin Zhu; Yan-li Wang; Jie-peng Chen; Li-li Duan; Pei-fang Cong; Ying-chun Qu; Jesse Li-Ling; Mei-xia Zhang
Journal:  Tumour Biol       Date:  2014-02

4.  Paired Expression Analysis of Tumor Cell Surface Antigens.

Authors:  Rimas J Orentas; Sivasish Sindiri; Christine Duris; Xinyu Wen; Jianbin He; Jun S Wei; Jason Jarzembowski; Javed Khan
Journal:  Front Oncol       Date:  2017-08-21       Impact factor: 6.244

5.  Expression and role of GPR87 in urothelial carcinoma of the bladder.

Authors:  Homare Okazoe; Xia Zhang; Dage Liu; Shinsuke Shibuya; Nobufumi Ueda; Mikio Sugimoto; Yoshiyuki Kakehi
Journal:  Int J Mol Sci       Date:  2013-06-10       Impact factor: 5.923

6.  EDG2 enhanced the progression of hepatocellular carcinoma by LPA/PI3K/AKT/ mTOR signaling.

Authors:  Meng Xu; Zhikui Liu; Cong Wang; Bowen Yao; Xin Zheng
Journal:  Oncotarget       Date:  2017-08-02

7.  Alpha conotoxin-BuIA globular isomer is a competitive antagonist for oleoyl-L-alpha-lysophosphatidic acid binding to LPAR6; A molecular dynamics study.

Authors:  Saima Younis; Sajid Rashid
Journal:  PLoS One       Date:  2017-12-06       Impact factor: 3.240

Review 8.  Lysophosphatidic Acid Receptor Antagonists and Cancer: The Current Trends, Clinical Implications, and Trials.

Authors:  Yu-Hsuan Lin; Yueh-Chien Lin; Chien-Chin Chen
Journal:  Cells       Date:  2021-06-29       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.